Breast Cancer Research: What’s the Latest?

Breast cancer research makes possible the development of new therapies for breast cancer. Through clinical trials and work in research labs, including those at Dana-Farber Cancer Institute, treatments and drugs are explored — and if successful, are later able to be offered to patients who need them. Breast cancer today is seen as not one, … Read more

Research Drives Key Protein from the Shadows to Reveal Its Role in Breast Cancer Subtype 

In a branch of the PI3K protein family — with members named PI3Kα, PI3Kβ, PI3Kδ, and PI3Kγ — PI3Kβ was long treated as the proverbial middle child: neglected by cancer scientists in favor of its more prominent siblings.  In a new study, Dana-Farber researchers demonstrate that it doesn’t deserve its obscurity — that in fact … Read more

Advances in Myeloma, Breast Cancer, and Clinical Trials Equity: A Dana-Farber Research Update

Results of several phase 3 trials and dozens of other studies led by Dana-Farber researchers were presented online and in person June 3-7 at the 2022 Annual Meeting of the American Society of Clinical Oncology (ASCO), the world’s largest clinical cancer research meeting. Some of the research reports presented by Dana-Farber investigators include: Improved progression-free … Read more

Cancer Conversations Podcast – Episode #5: What’s New in Metastatic Breast Cancer Treatment and Research

Although there is no cure for metastatic breast cancer, new developments in treatment and research are helping patients live longer and experience a better quality of life. In this Cancer Conversations podcast episode, Eric Winer, MD, director of Breast Oncology Program in the Susan F. Smith Center for Women’s Cancers at Dana-Farber, discusses the latest … Read more

Promising Research Developments Stir Hopes for Melanoma, Lung, Breast and Ovarian Cancer

The growing excitement about the potential of immunotherapy treatments for cancer continued at the 2015 meeting of the American Association for Cancer Research (AACR), one of the largest cancer research meetings of the year. Several Dana-Farber investigators presented encouraging results of immunotherapy for melanoma, lung cancer, and breast cancer. F. Stephen Hodi, MD, and Leena … Read more

Webchat: The Latest in Breast Cancer Treatment and Research

With new approaches to therapy and increased understanding of the biology of cancer, breast cancer treatment has made significant progress in recent years. “I am personally very excited about what’s to come for breast cancer treatment,” says Eric Winer, MD, director of the Breast Oncology Program in the Susan F. Smith Center for Women’s Cancers … Read more

New Research Shows Progress in Breast Cancer Treatment

The 36th annual San Antonio Breast Cancer Symposium, which ran from Dec. 10-14, brought news of significant advances against a disease that strikes more than 230,000 women and 2,000 men in the United States each year. The more than 1,000 research papers presented by thousands of scientists and physicians ranged from laboratory explorations of the … Read more

Improving Everything: How Movement and Exercise Helped One Breast Cancer Patient Restore Her Mobility and More

 When Sandra Noack returned home from a visit to Bogota, Colombia, to visit her family, there was a letter waiting for her. It was a leaflet sent via the Massachusetts Department of Public Health describing a clinical trial at Dana-Farber Cancer Institute for Latina and Hispanic breast cancer survivors.  The trial didn’t involve any medicine. … Read more

Cervical Cancer Disparities: What to Know and Tips for Prevention 

Cervical cancer is caused by a virus called HPV (human papilloma virus) that is spread through sexual contact. For many people, the virus is cleared by the immune system. But if it isn’t, it can develop into cancer.   The virus can be detected through HPV screening that inspects a sample of cervical tissue for the … Read more

Boston Marathon Run is Mother-Daughter Moment for Breast and Uterine Cancer Survivor 

Runners call it Heartbreak Hill, but for Michelle O’Brien the long, rising stretch of pavement that crosses the 20-mile point of the Boston Marathon® route represents the top of the mountain.   Just over three years after being diagnosed in back-to-back months with two unrelated cancers — invasive breast cancer in December 2020, and then stage … Read more

Patient with Breast Cancer Lives Her Best Life with the Help of a Team 

Thirteen years after Vici Robinson was treated for estrogen receptor-positive breast cancer, she began experiencing shortness of breath. Her local physicians in New Hampshire determined her symptoms came from liquid that was filling her lung.  Then came the shocking news that this was caused by a breast cancer recurrence which had metastasized.  At 81, Robinson … Read more

Metastatic Breast Cancer Survivor Proves Her Endurance at NYC Marathon 

When Meghan MacDonald visited her primary care provider in the fall of 2022 to get a lump in her breast examined, they confirmed her suspicion that it was just an inflamed cyst. Relieved, MacDonald began a course of antibiotics, but when the lump didn’t go away, her doctor ordered a mammogram, and when the results … Read more